Showing results (601-610 of 818) with videos related to
Sort By:
Pageof 82
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.Brain : a Journal of Neurology|April 1, 1992
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's diseaseV M Mann, J M Cooper, D Krige, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's diseaseF Stocchi, S Ruggieri, A Carta, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy?H Meierkord, D R Fish, S J Smith, et al.The Journal of Physiology|September 1, 1991
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in manY Ugawa, B L Day, J C Rothwell, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPM D Taylor, M L de Ceballos, S Rose, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1976
Bromocriptine treatment in Parkinson's diseaseJ D Parkes, C D Marsden, I Donaldson, et al.Neuroscience Letters|June 18, 1986
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigraA J Bradbury, B Costall, A M Domeney, et al.Brain : a Journal of Neurology|February 1, 1992
Cognitive performance in multiple system atrophyT W Robbins, M James, K W Lange, et al.Brain Research. Molecular Brain Research|December 24, 1997
Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's diseaseD J Eve, A P Nisbet, A E Kingsbury, et al.Pageof 82